BLCO Logo

Bausch + Lomb Corporation (BLCO) 

NYSE
Market Cap
$6.3B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
184 of 960
Rank in Industry
11 of 49

Largest Insider Buys in Sector

BLCO Stock Price History Chart

BLCO Stock Performance

About Bausch + Lomb Corporation

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. …

Insider Activity of Bausch + Lomb Corporation

Over the last 12 months, insiders at Bausch + Lomb Corporation have bought $505,067 and sold $0 worth of Bausch + Lomb Corporation stock.

On average, over the past 5 years, insiders at Bausch + Lomb Corporation have bought $505,067 and sold $1.35B worth of stock each year.

Highest buying activity among insiders over the last 12 months: SAUNDERS BRENT L (CEO and Chairman of the Board) — $2.02M.

The last purchase of 32,250 shares for transaction amount of $505,067 was made by SAUNDERS BRENT L (CEO and Chairman of the Board) on 2024‑08‑05.

List of Insider Buy and Sell Transactions, Bausch + Lomb Corporation

2024-08-05PurchaseCEO and Chairman of the Board
32,250
0.0093%
$15.66$505,067+24.22%
2022-06-01Sale
9.1M
2.724%
$17.05$155.21M-1.47%
2022-05-10Sale
70M
19.4359%
$17.05$1.19B-8.60%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Fil Ltd$141.6M2.338.19M+0.86%+$1.21M0.14
GoldenTree Asset Management$81.58M1.344.72M0%+$07.14
Maple Rock Capital Partners Inc$64.79M1.063.75M0%+$04.1
ICAHN CARL C$60.55M13.5M0%+$00.54
River Road Asset Management$32.66M0.541.89M-2.59%-$867,456.590.44
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.